1. Reducing the risk of arrhythmia with antiarrhythmics

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. No association has been proven between fluoxetine and suicidal ideation

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. Paracetamol should not generally be used for prophylaxis of vaccine-induced fever in children

   Newsletter Article 27 January 2013 Pages: 2 - 2

4. Caffeine - a possible drug abuse model

   Newsletter Article 27 January 2013 Pages: 2 - 3

5. Aciclovir

   Newsletter Article 27 January 2013 Pages: 3 - 3

6. Alcohol see Nifedipine interaction

   Newsletter Article 27 January 2013 Pages: 3 - 3

7. Alfentanil interaction

   Newsletter Article 27 January 2013 Pages: 3 - 3

8. Allopurinol

   Newsletter Article 27 January 2013 Pages: 3 - 3

9. Aluminium hydroxide

   Newsletter Article 27 January 2013 Pages: 3 - 4

10. Amineptine poisoning

    Newsletter Article 27 January 2013 Pages: 4 - 4

11. Aminophylline poisoning

    Newsletter Article 27 January 2013 Pages: 4 - 4

12. Anabolic steroids abuse

    Newsletter Article 27 January 2013 Pages: 4 - 4

13. Antineoplastics

    Newsletter Article 27 January 2013 Pages: 4 - 4

14. Antituberculars

    Newsletter Article 27 January 2013 Pages: 4 - 4

15. Azathioprine

    Newsletter Article 27 January 2013 Pages: 4 - 5

16. Beclobrate

    Newsletter Article 27 January 2013 Pages: 5 - 5

17. Befunolol/timolol/betaxolol

    Newsletter Article 27 January 2013 Pages: 5 - 5

18. Betaxolol see Befunolol/timolol/betaxolol

    Newsletter Article 27 January 2013 Pages: 5 - 5

19. Captopril

    Newsletter Article 27 January 2013 Pages: 5 - 5

20. Ciprofloxacin

    Newsletter Article 27 January 2013 Pages: 5 - 5

21. Contrast media

    Newsletter Article 27 January 2013 Pages: 5 - 5

22. Digoxin overdose

    Newsletter Article 27 January 2013 Pages: 5 - 5

23. Enoxacin/xipamide

    Newsletter Article 27 January 2013 Pages: 5 - 6

24. Epoetin

    Newsletter Article 27 January 2013 Pages: 6 - 6

25. Erythromycin see Alfentanil interaction

    Newsletter Article 27 January 2013 Pages: 6 - 6

26. Estradiol

    Newsletter Article 27 January 2013 Pages: 6 - 6

27. Fluconazole interaction

    Newsletter Article 27 January 2013 Pages: 6 - 6

28. Growth hormone human/somatrem

    Newsletter Article 27 January 2013 Pages: 6 - 6

29. Halothane/lidocaine

    Newsletter Article 27 January 2013 Pages: 6 - 7

30. Hydrochlorothiazide see Methyldopa/hydrochlorothiazide

    Newsletter Article 27 January 2013 Pages: 7 - 7

31. Immunoglobulin G

    Newsletter Article 27 January 2013 Pages: 7 - 7

32. Interferon alpha

    Newsletter Article 27 January 2013 Pages: 7 - 7

33. Lidocaine

    Newsletter Article 27 January 2013 Pages: 7 - 7

34. Lidocaine see Halothane/lidocaine

    Newsletter Article 27 January 2013 Pages: 7 - 7

35. Loperamide poisoning

    Newsletter Article 27 January 2013 Pages: 7 - 7

36. Methyldopa/hydrochlorothiazide

    Newsletter Article 27 January 2013 Pages: 7 - 7

37. Methyldopa

    Newsletter Article 27 January 2013 Pages: 7 - 7

38. Mexiletine interaction

    Newsletter Article 27 January 2013 Pages: 7 - 7

39. Minoxidil

    Newsletter Article 27 January 2013 Pages: 7 - 8

40. Nifedipine interaction

    Newsletter Article 27 January 2013 Pages: 8 - 8

41. Oral contraceptives

    Newsletter Article 27 January 2013 Pages: 8 - 8

42. Phenytoin see Mexiletine interaction

    Newsletter Article 27 January 2013 Pages: 8 - 8

43. Rifampicin see Fluconazole interaction

    Newsletter Article 27 January 2013 Pages: 8 - 8

44. Somatrem see Growth hormone human/somatrem

    Newsletter Article 27 January 2013 Pages: 8 - 8

45. Streptokinase

    Newsletter Article 27 January 2013 Pages: 8 - 8

46. Sulfasalazine

    Newsletter Article 27 January 2013 Pages: 8 - 8

47. Timolol see Befunolol/timolol/betaxolol

    Newsletter Article 27 January 2013 Pages: 8 - 8

48. Tretinoin

    Newsletter Article 27 January 2013 Pages: 8 - 8

49. Tryptophan

    Newsletter Article 27 January 2013 Pages: 8 - 8

50. Xipamide see Enoxacin/xipamide

    Newsletter Article 27 January 2013 Pages: 8 - 8